ArticleWomen's health reports (New Rochelle, N.Y.)
Women and Herpes Zoster in the United States: Risk and Prevention Management-A Narrative Review.
Article in Women's health reports (New Rochelle, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Herpes zoster (HZ), also known as shingles, is caused by reactivation of the latent varicella-zoster virus. HZ commonly manifests as a painful rash but may lead to more severe complications. An estimated 1 million cases of HZ occur annually in the United States, with adults aged ≥50 years, women, and individuals living with certain underlying conditions at increased risk compared with the general population. This narrative review aims to support the provision of comprehensive HZ-preventive care to female patients through consolidating evidence on risk factors for HZ and current prevention practices. Risk Factors for HZ: Evidence shows that women are at an increased risk of developing HZ and related complications. A variety of risk factors may contribute to this increased risk among women. Some are specific to women, including certain cancers. Other risk factors include chronic conditions and immune diseases with increased prevalence among women, such as rheumatoid arthritis and systemic lupus erythematosus. HZ Prevention Practices: Gaps in HZ prevention persist, including in recombinant zoster vaccine uptake and disparities in vaccination uptake by race and ethnicity. Various methods have been proposed that aim to address gaps in prevention, including approaching vaccination outside of the traditional primary care setting and considering the educational and resource needs of women's health providers.Guidelines and resources from the Centers for Disease Control and Prevention and medical societies are among the tools available to primary care providers and specialists in the women's health space, such as obstetricians/gynecologists and oncologists, to support the incorporation of HZ-preventive care into clinicians' practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.